Brian T. Helfand, Ph.D.
Affiliations: | 2003 | Northwestern University, Evanston, IL |
Area:
Cell Biology, Molecular NeuroscienceGoogle:
"Brian Helfand"Mean distance: 26716.5
Parents
Sign in to add mentor| Robert D. Goldman | grad student | 2003 | Northwestern | |
| (Mechanisms underlying intermediate filament motility: Implications for cell shape and disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oumedjbeur K, Corsi NJ, Bouhadana D, et al. (2023) Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50-80 mL. The Canadian Journal of Urology. 30: 11650-11658 |
| Kearns JT, Helfand BT. (2023) Is Active Surveillance Too Active? Current Urology Reports |
| Surasi DS, Eiber M, Maurer T, et al. (2023) Diagnostic Performance and Safety of Positron Emission Tomography with F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE). European Urology |
| Seibert TM, Garraway IP, Plym A, et al. (2023) Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. European Urology |
| Wei J, Beebe-Dimmer J, Shi Z, et al. (2022) Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate |
| Glaser A, Shi Z, Wei J, et al. (2022) Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer. European Urology Open Science. 43: 54-61 |
| Kearns JT, Helfand BT, Xu J. (2022) Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice. European Urology Focus |
| Helfand BT, Paterakos M, Wang CH, et al. (2022) The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer. Plos One. 17: e0273782 |
| Andolfi C, Vickers AJ, Cooperberg MR, et al. (2022) Blood prostate-specific antigen by volume of benign, Gleason pattern 3 and 4 prostate tissue. Urology |
| Helfand BT, Kasraeian A, Sterious S, et al. (2022) How I do it: Aquablation in very large prostates (> 150 mL). The Canadian Journal of Urology. 29: 11111-11115 |